Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial
2022 · Nature Cancer · 62 citations
https://doi.org/10.1038/s43018-022-00503-w
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
20
Papers
2.8K
Citations
15
h-index
15
i10-index
Ulrike Schäkel is an academic researcher from Heidelberg University. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Chronic Myeloid Leukemia Treatments & COVID-19 Clinical Research Studies. The author has an h-index of 15, co-authored 17 publications.
https://doi.org/10.1038/s43018-022-00503-w
https://doi.org/10.1186/s13063-020-04735-y
Click to start Chat